HUMAN AMYLOID IMAGING CONFERENCE

The 17th edition of the HAI was held in San Juan, Puerto Rico on January 15-17, 2025.

HAI 2025 POSTER SESSIONS

Click the “+” to open each module; tables can be sorted by clicking on each item of the header row (board number, poster title, authors and presenter, respectively). Additionally, each table is searchable (use the search field located at the top right of each module).

Please note that we reserve the right to re-arrange the poster allocation.

POSTER SESSIONS: 1A - Wednesday, January 15 - 10:40 am - 12:35 pm; 1B - Wednesday, January 15, 4:30 - 5:25 pm

Board #	Title	Authors	Presenter
01	Decline in everyday functioning over time relates to amyloid and tau in cognitively unimpaired older adults	Dubbelman \| Liu \| Donohue \| Langford \| Raman \| Rentz \| Amariglio \| Sperling \| Aisen \| Marshall	Dubbelman, Mark
02	From the clinical utility of a-synuclein PET imaging in Multiple System Atrophy to the possible diagnosis of Parkinson’s disease	Vokali \| Molette \| Rodriguez \| Changizi2 \| Kuzkina \| Ravache \| Dimitrakopoulos \| Delgado \| Kocher \| Pittet \| Vallet \| Hliva \| Pfeifer \| Kosco-Vilbois \| Derouazi \| Khurana \| Capotosti	Capotosti, Francesca
03	Unraveling the impact of amyloid-β and tau pathology on brain structure and cognitive function during preclinical and prodromal Alzheimer’s disease	Qiu \| Liu \| Gallego-Rudolf \| Edde \| Caron \| Zhang \| Soucy \| Spreng \| Descoteaux \| Villeneuve	Qiu, Ting
04	Astrogliosis, a potential non-Aβ pathway to tau	Villemagne \| Cohen \| Lopresti \| Saeed \| Tudorascu \| Gogola \| Matan \| Reese \| Snitz \| Ikonomovic \| Reis \| Launer \| Lopez	Villemagne, Victor L
05	APOE ε4 carriers exhibit attenuated habituation in pupil size and practice effects on a repeated auditory oddball task	Grube \| Rodríguez Alonso \| Engels-Domínguez \| Jacobs \| Riphagen	Grube, Jill
06	Baseline tau burden and performance on a digital clock drawing test uniquely contributes to predicting future tau accumulation in preclinical AD	Fu \| Robinson \| Farrell \| Jutten \| Thibault \| Rodriguez Alonso \| Thompson \| Lois \| Tiss \| Gong \| Chen \| Penney \| Davis \| Sperling \| Johnson \| Rentz \| Price	Fu, Jessie Fang-Lu
07	Molecular correlates of apraxia in Alzheimer's disease: A PET imaging study	Bischof \| Jaeger \| Giehl \| jessen \| Onur \| O'Bryant \| Kara \| Weiss \| Drzezga	Bischof, Gerard
08	Understanding the impact of race on white matter hyperintensities in Alzheimer’s disease: Findings from the ADNI Study	Ekuta \| Ahn \| Tripodis \| Hamilton	Ekuta, Victor
09	Characterization of a limbic-predominant amnestic neurodegenerative syndrome	Corriveau-Lecavalier \| Waniger \| Stricker \| Machulda \| Fields \| Botha \| Graff-Radford \| Ramanan \| McCarter \| Nguyen \| Reichard \| Boeve \| Knopman \| Lowe \| Dickson \| Murray \| Graff-Radford \| Petersen \| Jack \| Jones	Corriveau-Lecavalier, Nick
10	Positron emission tomography analysis with the dynamicpet Python package	Bilgel \| Amer \| Bae \| Bouhrara \| Gong \| Guo \| Uriarte-Lopez \| Singh \| Matheson \| Nørgaard	Bilgel, Murat
11	Targeted plasma eQTL and pQTL to identify potential novel biomarker for Alzheimer's Disease in African Americans	Colón-Badillo \| Reddy \| Jin \| Lincoln \| Ho \| Crook \| Wang \| Malphrus \| Nguyen \| Marrero-Polanco \| Tamvaka \| Lucas \| Graff-Radford \| Ertekin-Taner \| Carrasquillo	Colón-Badillo, Vanessa
12	Pathological and clinical trajectories of preclinical Alzheimer’s disease patients with divergent cortical tau patterns	Young \| Carlson \| Cody \| Winer \| Schultz \| Mormino	Mormino, Elizabeth
13	Evaluation of a label-free X-ray based method for estimating amyloid load in the human brain	Geremia \| Amer \| Dahal \| Badano	Geremia, Danielle
14	Proteomic analyses of A-T-N reveal plasma mediators of neurodegeneration and dementia risk	Duggan \| Bilgel \| Chen \| Moghekar \| Davatzikos \| Coresh \| Resnick \| Walker	Duggan, Michael
15	The spatial spread of tauopathy precedes the increase in tau-PET load in Alzheimer’s disease	Cassa Macedo \| Therriault \| Rahmouni \| Tissot \| Aumont \| Wang \| Servaes \| Trudel \| Hall \| Hosseini \| Fernandez-Arias \| Bezgin \| Chan \| Zheng \| Ferrari-Souza \| Ferreira \| Bellaver \| Lussier \| Pascoal \| Rosa-Neto	Cassa Macedo, Arthur
16	Distinct patterns of Iron distribution in the entorhinal cortex-hippocampus system for characterization of mild cognitive impairment	Kagerer \| Vionnet \| van Bergen \| Meyer \| Gietl \| Prüssmann \| Hock \| Unschuld	Unschuld, Paul
17	Pathological asymmetry in early onset AD reflects heterogenous disease trajectories	Ziontz \| Maiti \| Zhang \| Chiotis \| Blazhenets \| Rocha \| Shankar \| Amuiri \| Schonhaut \| Hammers \| Eloyan \| Koeppe \| Carrillo \| Dickerson \| Apostolova \| Rabinovici \| La Joie	Ziontz, Jacob
18	Characterizing amyloid-positive with low Tau (A+T-) profiles and their association with cognitive trajectories in the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS): A multi-method approach	Abu Raya \| Soleimani-Meigooni \| Schonhaut \| Blazhenets \| Chiotis \| Lagarde \| Vrillon \| Maiti \| Windon \| Zeltzer \| Zhang \| Yballa \| Shankar \| Amuiri \| Rocha \| Hammers \| Eloyan \| Carrillo \| Koeppe \| Dickerson \| Apostolova \| Rabinovici \| La Joie	Abu Raya, Maison
19	The association between amyloid and physical activity in a racially diverse cohort of older adults	Dong \| Wu \| Minhas \| Laymon \| Villemagne \| Lopez \| Snitz \| Gogniat \| Glynn \| Tudorascu \| Cohen	Dong, Yiwen
20	Whole blood gene expression is associated with plasma p-tau217 levels via amyloid-PET and sex	Buckley \| Janve \| Seto \| Klinger \| Brown \| Birkenbihl \| Coughlan \| Townsend \| Properzi \| Zyski \| Wang \| Clifton \| Hanseeuw \| Chhatwal \| Yang \| Rissman \| Aisen \| Cuppels \| Donohue \| Raman \| Johnson \| Sperling \| Dumitrescu \| Hohman	Buckley, Rachel
21	Plasma Aβ as predictor of Aβ accumulation in non-demented participants	Gogola \| Cohen \| Lopresti \| Snitz \| Ikonomovic \| Tudorascu \| Minhas \| Kofler \| Matan \| Aizentein \| Lopez \| Karikari \| Villemagne	Gogola, Alexandra
22	The relative prevalence of tau severity stages is related to amyloid burden, clinical diagnosis and age	Cody \| Sokolowski \| Carlson \| Medina \| Winer \| Young \| Younes \| Durant \| Dumitrescu \| Archer \| Tosun-Turgut \| Johnson \| Harrison \| Hohman \| Mormino	Cody, Karly
23	Head-to-head trajectories of tau PET and plasma p-tau217 as a function of Aβ	Bellaver \| Povala \| L. Ferreira \| Bauer-Negrini \| Lussier \| Amaral \| Soares \| Rocha \| Masdeu \| Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| A. Gordon \| Rosa-Neto \| Baker \| A. Pascoal	Bellaver, Bruna
24	Functional submodules in the human locus coeruleus are differentially susceptible to tau pathology	Lawn \| Prokopiou \| Van Egroo \| Ashton \| Janelidze \| Blennow \| Hansson \| Zetterberg \| Jacobs	Lawn, Timothy
25	Sex-specific associations of BMI, amyloid, and regional tau deposition in community-dwelling cognitively normal older adults	Gills \| Cesar \| Dominguez \| Sogade \| Browne \| Weisgerber \| McBride \| Valkanova \| Mbah \| Figueredo \| Jean-Louis \| Masurkar \| Osorio \| Bubu	Gills, Joshua
26	Assessment of ATN with a single dynamic [18]F-PI-2620 recording	Gnörich \| Kusche-Palenga \| Kling \| Zatcepin \| Dehsarvi \| Bronte \| Zaganjori \| Frontzkowski \| Roemer \| Groß \| Schöberl \| Scheifele \| Bauer \| Bernhardt \| Jäck \| van Eimeren \| Drzezga \| Perneczky \| Bürger \| Levin \| Bartenstein \| Sabri \| Barthel \| Rullmann \| Stöcklein \| Höglinger \| Franzmeier \| Brendel	Gnörich, Johannes
27	Tau-PET detects advanced primary age-related tauopathy mimicking early-stage AD	Grothe \| Moscoso \| Labrador-Espinosa \| Silva-Rodríguez \| Heeman \| Costoya-Sánchez \| Camacho \| van Essen \| Mainta \| Perissinotti \| Rodríguez-Fonseca \| Ribaldi \| Devous, Sr. \| Pontecorvo \| Frisoni \| Garibotto \| Schöll	Grothe, Michel
28	Amyloid status moderates associations between hippocampal microstructure, PET tau burden, and memory in dementia-free older adults	Callow \| Rani \| Alm \| Pettigrew \| Soldan \| Miller \| Albert \| Bakker	Callow, Daniel
29	Performance of an MR-independent analysis pipeline for quantification of tau abnormality using [18F]flortaucipir PET	DelBene \| Gogola \| Reese \| Matan \| Chiang \| Snitz \| Cohen \| Lopez \| Villemagne \| Lopresti	DelBene, Alexander
30	Functional and structural connectivity patterns predict longitudinal tau spreading in asymptomatic individuals expressing Aβ pathology	Gallego-Rudolf \| Qiu \| Javanray \| Wiesman \| St-Onge \| Fajardo-Valdez \| Baillet \| Villeneuve	Gallego-Rudolf, Jonathan
31	Plasma phospho-tau 217, neurofilament-light, and glial fibrillary acidic protein are differentially associated with longitudinal neuropsychiatric symptoms across the early cognitive spectrum	Gatchel \| Yu \| Palmer \| Wu \| Beltran \| Munro \| Webb \| Blacker \| Arnold \| Marshall \| Dodge	Gatchel, Jennifer R
32	An assessment of the utility of flortaucipir PET to detect four-repeat tau pathology in a globular glia tauopathy case-series	Gatto \| Youssef \| Ghatamaneni \| Uruk \| Min \| Fu \| Reichard \| Lowe \| Dickson \| Whitwell \| Josephs	Gatto, Rodolfo
33	Molecular imaging of neurodegeneration – mitochondria, associated proteins and synapses (MIND-MAPS) in frontotemporal dementia	Clarke \| Whittington \| Passchier \| Lewis \| Passamonti \| Chen \| Salinas \| Tsukada \| Cash \| Rabiner \| Rohrer	Clarke, Mica
34	Evaluating tVNS effects on cognitive outcomes and modulating factors in asymptomatic older adults: study design of the WALLe Trial	Engels-Domínguez \| Grube \| Fenlon \| Wiklund \| Heinrich \| Baillet \| van Egroo \| Papp \| Riphagen \| Garcia \| Sclocco \| Johnson \| Napadow \| Jacobs	Engels-Domínguez, Nina
35	Cerebral perfusion indices from early-phase [18F]-MK6240 dynamic Tau PET imaging in brain regions associated with Alzheimer’s Disease progression in an aging population.	Dhaynaut \| Lois \| Tiss \| Thibault \| Fanglu Fu \| Ouyang \| Johnson \| El Fakhri \| Normandin \| Guehl	Dhaynaut, Maeva
36	Transcutaneous auricular vagus nerve stimulation improves learning and sleep-wake quality in older APOE-ε4 carriers	Baillet \| Van Egroo \| Engels-Domínguez \| Grube \| Fenlon \| Wiklund \| Heinrich \| Riphagen \| Papp \| Garcia \| Sclocco \| Napadow \| Jacobs	Baillet, Marion
37	Biological-clinical mismatch reflects co-pathology and vulnerability to neurodegeneration	Brown \| Das \| Xie \| Nasrallah \| Detre \| Yushkevich \| McMillan \| Wolk	Brown, Christopher
38	Validation of PET spatial extent as sensitive amyloid biomarker in early stages of amyloidosis	Del Carmen Montenegro \| Thibault \| Fanglu Fu \| Price \| Hanseeuw \| Jacobs \| Sperling \| Johnson \| Farrell	Del Carmen Montenegro, Grace
39	Developing a novel reference region for PI-2620-PET imaging to facilitate assessment of 4-repeat tauopathies	L. Frontzkowski; M. Gross; J. Gnörich, A. Dewenter; A. Desharvi; M. Malpetti; S. Roemer; A. Steward; F. Wagner; M. Brendel; N. Franzmeier	Frontzkowski, Lukas
40	P-TAU217, GFAP, and NFL plasma biomarker associations with demographic, medical and neurocognitive features from middle-aged through older adulthood	Arnold \| Kivisakk \| Fatima \| Gentsch \| Cruchaga \| Wu \| Dodge \| Ances \| Salat	Arnold, Steven
41	DeepSUVR: Using temporal constraints to improve tau quantification	Bourgeat \| Fripp \| Gillman \| Feizpour \| Schwarz \| Jack \| Lowe \| Weiner \| Masters \| Villemagne \| Rowe \| Dore	Bourgeat, Pierrick
42	Increasing the granularity of tau-PET Braak staging using medial temporal lobe segmentations to detect early memory impairment	Aumont \| Hall \| Trudel \| Chan \| Hosseini \| Macedo \| Fernandez Arias \| Rahmouni \| Therriault \| Servaes \| Bezgin \| Stevenson \| Rosa-Neto	Aumont, Etienne
43	The universal tau PET scale (Uni𝜏) for Flortaucipir, MK6240, PI2620 and RO948 harmonization	Povala \| Bauer-Negrini \| Bellaver \| Z. Lussier \| Amaral \| Lukasewicz Ferreira \| L. Tudorascu \| Finn \| Masdeu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| A. Gordon \| Rosa-Neto \| Baker \| A. Pascoal	Povala, Guilherme
44	Assessing the relationship between neuropsychiatric symptoms, amyloid and tau pathology, and white matter hyperintensity volume across sexes in preclinical Alzheimer’s disease	Garrone \| Yakoub \| Fajardo-Valdez \| Qiu \| Ourry \| Villeneuve	Garrone, Aurélie
45	Unveiling the heterogeneity of tau spreading in aging and Alzheimer's disease using polygenic combinations: Towards personalized models	Diez \| Lois \| Garcia Condado \| Farrell \| Thibault \| Jacobs \| Buckley \| Hanseeuw \| Properzi \| Yang \| Sperling \| Cortes \| Quiroz \| Sepulcre \| Johnson \| Gomez-Isla	Diez, Ibai
46	Regional amyloid and tau: Exploring regional sex-based differences in a middle-aged community-based cohort	Guzmán \| Aziz \| Smith \| Houlihan \| Sanchez \| Luchsinger \| Lao	Guzmán, Diana S
47	Comparison of topographical patterns of abnormalities of the tau PET tracers [18F]Flortaucipir, [18F]MK6240, [18F]PI2620, and [18F]RO948	Amaral \| Povala \| Bauer-Negrini \| Ruppert \| Bellaver \| Lussier \| L. Ferreira \| Masdeu \| Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Amaral, Livia
48	Subtle cognitive deficits detected through routine in-office tests are associated with global Aβ and temporal tau in cognitively unimpaired individuals	Felix \| Rebok \| Kollasserry \| Snitz \| Ferreira \| Tudorascu \| Povala \| Saha \| Amaral \| Lussier \| Masdeu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Gordon \| Rosa-Nato \| Baker \| Nasreddine \| Pascoal	Felix, Cynthia
49	Estradiol-dependent associations between sleep complaints and tau deposition in women at elevated AD risk	Lui \| Wang \| Deyong \| Malhotra \| Sundermann \| Banks	Banks, Sarah
50	Impact of age and sex on extra-cerebral off-target binding in tau PET scans (18F-FTP)	Ghatamaneni \| Kim \| Nycklemoe \| Lundt \| Schwarz \| Kandimalla \| Jacobson \| Albertson \| Jack \| Gunter \| Peterson \| kung \| sharma \| seokbeen \| Lowe \| Min	Ghatamaneni, Sujala
51	Metabolic inefficiency is associated with regional vulnerability to tau deposition	Adams \| Parker \| Zhao \| Yassa	Adams, Jenna
52	Relationship between Polygenetic Risk Score of BrainAge and plasma biomarkers in the A4/Elearn Study	Garcia Condado \| Birkenbihl \| Cortes \| Buckley \| Diez	Garcia Condado, Jorge
53	Combined impact of plasma phospho-tau 217 and NfL on longitudinal domain-specific cognitive decline	Dodge \| Wu \| Chen \| Gatchel \| Das \| Kivisäkk \| Arnold	Dodge, Hiroko
54	Comparison of distribution volume and standardized uptake value ratio for a MAO-B tracer in mild cognitive impairment	Bezgin \| Rahmouni \| Harada \| Okamura \| Benedet \| Ashton \| Zetterberg \| Blennow \| Rosa-Neto	Bezgin, Gleb
55	Association between early and late tau aggregation across tau imaging agents: The HEAD Study	Rahmouni \| Tissot \| Therriault \| Hosseini \| Macedo \| Servaes \| Lussier \| Trudel \| Hall \| Fernandez-Arias \| Wang \| Stevenson \| Gauthier \| Baker \| Pascoal \| Rosa-Neto	Rahmouni, Nesrine
56	The impact of spatial smoothing on the accuracy of Centiloid thresholds	Fajardo-Valdez \| Qiu \| Gallego-Rudolf \| Javanray \| Villeneuve	Fajardo-Valdez, Alfonso
57	Longitudinal amyloid PET trajectories in the HABS-HD cohort	Betthauser \| Morse \| Heston \| Langhough \| Carey \| Wisch \| Ances \| Cohen \| Toga \| Braskie \| Zuelsdorff \| O'Bryant \| Meeker	Betthauser, Tobey
58	Lower microstructural integrity of the locus coeruleus to entorhinal cortex pathway is related to elevated astrocyte reactivity and tau burden in cognitively unimpaired individuals: a 7T dMRI study	Patsyuk \| Van Egroo \| Beckers \| Ashton \| Janelidze \| Blennow \| Hansson \| Zetterberg \| Poser \| Jacobs	Patsyuk, Yuliya

POSTER SESSIONS: 2A - Thursday, January 16 - 10:05 - 11:00 am; 2B - Thursday, January 16, 3:55 - 4:50 pm

Board #	Title	Authors	Presenter
59	Interpretable prediction of amyloid PET positivity using non-negative matrix factorization	Zhang \| Barnard \| Gogineni \| Corriveau-Lecavalier \| Botha \| Burkett \| Johnson \| Lowe \| McCarter \| Ramanan \| Graff-Radford \| Knopman \| Petersen \| Jones	Jones, David
60	Data-driven biomarker discovery nominates novel diagnostic plasma biomarkers and provides insights into Alzheimer’s disease pathophysiology in an African American cohort	Kuchenbecker \| Thompson \| Hurst \| Opdenbosch \| Heckman \| Reddy \| Nguyen \| Casellas \| Sotelo \| Redy \| Lucas \| Day \| Willis \| Graff-Radford \| Ertekin-Taner \| Kalari \| Carrasquillo	Kuchenbecker, Lindsey
62	Longitudinal multicenter head-to-head harmonization of tau PET tracers: an overview of the HEAD study cohort	Lussier \| Povala \| Bauer-Negrini \| Silva do Amaral \| Lukasewicz Ferreira \| Bellaver \| Masdeu \| Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Lussier, Firoza
63	Higher time varying brain functional connectivity is associated with slower tau accumulation at the preclinical stage of Alzheimer’s disease	Javanray \| St-Onge \| Bellec \| Misic \| Soucy \| Villenueve	Javanray, Mohammadali
64	Graph convolutional networks to predict cognitive decline at the individual level in Alzheimer’s disease	Kang \| Heaton \| Nyman \| Biparva \| McSweeney \| Ottoy \| Masellis \| Shirzadi \| Johnson \| Sperling \| Schultz \| Jasmeer \| Swardfager \| Lipsman \| Black \| Rabin \| Goubran	Kang, Min Su
65	Low tau in Aβ-positive cognitively impaired individuals: Alzheimer’s disease or something more?	Ioannou \| Abdullaieva \| J. Perrin \| Bluma \| Poulakis \| Leuzy \| Religa \| Rodriguez-Vieitez \| Chiotis	Ioannou, Konstantinos
66	A plasma clock for Alzheimer disease based on %p-tau217	Petersen \| Milà-Alomà \| Tosun \| Li \| Shaw \| Dage \| Zetterberg \| Saef \| Holtzman \| Morris \| Xiong \| Bateman \| Bannon \| Potter \| Schindler	Petersen, Kellen K.
67	Network-based amyloid-β pathology predicts subsequent cognitive decline in cognitively normal older adults	He \| Razlighi \| Gazes \| Habeck \| Stern	He, Hengda
68	Associations between APOE-TOMM40 ‘523 haplotype variants and limbic system white matter microstructure in Black and White individuals	Mooney \| Archer \| Sathe \| Hohman \| Kadiri \| Lamar \| Arfanakis \| Yu \| Barnes \| Deters	Mooney, Katelyn
69	Multi element MRI template method for analysis of Down syndrome PET	Laymon \| Minhas \| Heffley \| Gilmore \| Kondaveeti \| Gogola \| Royse \| Joshi \| Lopresti \| Luo \| Davuluri \| Matan \| Tudorascu \| Christian \| Zaman \| Beau \| Cohen \| Handen	Laymon, Charles
70	Whole-blood gene expression associations with Aβ-PET accumulation and cognitive decline	Klinger \| Janve \| Seto \| Brown \| Birkenbihl \| Coughlan \| Townsend \| Zyski \| Wang \| Amariglio \| Papp \| Rentz \| Yang \| Chhatwal \| Clifton \| Donohue \| Raman \| Rissman \| Aisen \| Johnson \| Sperling \| Dumitrescu \| Hohman \| Buckley	Klinger, Hannah
71	Longitudinal change in five dominant dimensions of brain aging in relation to brain amyloid status and Alzheimer’s-related plasma biomarkers	Bilgel \| Shah \| Cooper \| An \| Walker \| Moghekar \| Yang \| Erus \| Davatzikos \| Resnick	Bilgel, Murat
72	Enrichment of patients with concomitant LATE on the Alzheimer’s disease continuum using hippocampal volume	Mundada \| Lyu \| Sadeghpour \| Brown \| McCrew \| Xie \| Yushkevich \| Das \| Wolk	Mundada, Nidhi
73	AT(N) staging of Alzheimer’s disease: Comparison of visual interpretation and automated quantification pipelines	Lopresti \| Cohen \| DelBene \| Reese \| Matan \| Gogola \| Chiang \| Snitz \| Royse \| Lopez \| Villemagne	Lopresti, Brian
74	MK-6240 off-target binding patterns in relation to microglia density, measured through TSPO PET	Heuer \| Johnson \| Smith \| Guzman \| Houlihan \| Okafor \| Sanchez \| Talmasov \| Dass \| Chikwem \| Provenzano \| Kreisl \| Noble \| Small \| Lao	Heuer, Lauren
75	Association between medication use and [18F]MK6240 and [18F]Flortaucipir uptake across the Alzheimer's disease spectrum	Mroué \| Lukasewicz Ferreira \| Povala \| Bellaver \| Bauer-Negrini \| Lussier \| Amaral \| Scop Medeiros \| Ruppert \| Silva da Rocha \| Scarpatto Rodrigues \| Silva Oliveira \| Soares Katz \| Teixeira Leffa \| Saha \| Felix \| Masdeu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Mroué, Rayan
76	Lower LC-EC tract integrity is associated with entorhinal tau in autosomal-dominant Alzheimer’s disease	Koops \| Giudicessi \| Bonillas-Felix \| Medrano \| Martinez \| Gonzalez \| Alvarez \| Aguillon \| Quiroz \| Jacobs	Koops, Elouise
77	APOE4 associated with higher off-target meninges signal with [F-18]MK6240 PET	McVea \| DiFilippo \| McLachlan \| Bettcher \| Tudorascu \| Johnson \| Zammit \| Betthauser \| Christian	McVea, Andrew
78	An accurate and automated technique for removing spill-over contamination and off-target retention from a cerebellar reference region for tau PET	Minhas \| DelBene \| Gogola \| Reese \| Luo \| Laymon \| Lopresti \| Dore \| Pascoal \| Baker \| Tudorascu \| Villemagne	Minhas, Davneet
79	Updated public CenTauR pipelines to measure CenTauR, CenTauRZ, and SUVR tau PET units	Schwarz \| Leuzy \| Doré \| Villemagne \| Xiao \| Pappas \| Przybelski \| Prakaashana \| Senjem \| Lowe \| Gunter \| Kantarci \| Vemuri \| Graff-Radford \| Petersen \| Knopman \| Jack	Schwarz, Christopher
80	Predicting regional Alzheimer’s disease pathology with plasma p-tau217 in preclinical AD	Moon \| Chen	Moon, Hasom
81	TSPO-PET before and after low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease	Pascual \| Faridar \| Finn \| Gamez \| Appel \| Masdeu	Pascual, Belen
82	In low neocortical tau individuals, high amygdala tau predicts faster cognitive decline	Hanseeuw \| Thibault \| Farell \| Buckley \| Properzi \| Gatchel \| Amariglio \| Marshall \| Beiser \| Seshadri \| De Carli \| Sperling \| Jacobs \| Johnson	Hanseeuw, Bernard
83	EOAD-signature atrophy predicts progression to dementia in patients with early-onset MCI due to Alzheimer’s disease	Paranhos \| Katsumi \| Brickhouse \| Eckbo \| Zaitsev \| Du \| Eloyan \| Nudelman \| Foroud \| Dage \| Carrillo \| Rabinovici \| Apostolova \| Dickerson \| Touroutoglou \| Consortium	Katsumi, Yuta
84	FDG reference region selection using PiB amyloid status-guided iterative normalization in a Down syndrome cohort	McLachlan \| Keator \| Price \| Tudorascu \| Laymon \| Cohen \| Lao \| Handen \| Fryer \| Ances \| Zaman \| Head \| Mapstone \| Bettcher \| Guerrero Gonzalez \| LeMerise \| McVea \| DiFillipo \| Zammit \| Hartley \| Christian	McLachlan, Max
85	Microscopic visualization of fluorescent MK-6240	Kunach \| S. Smith \| I. Antczak \| Gupta \| Monistrol \| Tripathi \| Jalapati \| Guiot \| Stoddard \| H. Shahmoradian \| K. Shoichet \| Vaquer-Alicea \| Rosa-Neto \| M. Ready \| I. Diamond	Kunach, Peter
86	Conversion of Tau PET SUVR data to CenTauR units using the Joint Propagation Model	Leuzy \| Raket \| Villemagne \| Klein \| Tonietto \| Olafson \| Baker \| Saad \| Bullich \| Lopresti \| Sanabria Bohorquez \| Lutz \| Boada \| Betthauser \| Charil \| Collins \| Collins \| Gunn \| Higuchi \| Hostetler \| Hutchison \| Iaccarino \| Insel \| Irizarry \| Jack Jr \| Jagust \| Johnson \| Johnson \| Karten \| Marquié \| Mathotaarachchi \| Mintun \| Ossenkoppele \| Pappas \| Petersen \| Rabinovici \| Rosa-Neto \| Schwarz \| Smith \| Stephens \| Whittington \| Carrillo \| Pontecorvo \| Haeberlein \| Dunn \| Kolb \| Stephenson \| Rowe \| Hansson \| Doré	Leuzy, Antoine
87	The role of cohort heterogeneity in predicting AD/ADRD cognitive decline	Liu \| Taggett \| Harrison \| Snyder \| DeCarli \| Vemuri \| Harvey \| Jagust \| Baker \| Landau	Liu, Peiwei
88	Differential tau accumulation in early-onset and late-onset Alzheimer's disease: Insights from [18F]-Florzolotau PET	Khurelbaatar \| Huang \| Lin \| Huang \| Hsu \| Huang \| Wu \| Huang \| Chang \| Hsiao	Khurelbaatar, Bayarjargal
89	Heterogeneity of FDG-PET patterns among tau-negative amnestic patients	Silva-Rodríguez \| Moscoso \| Labrador-Espinosa \| Sánchez-Juan \| Scholl \| Grothe	Silva-Rodríguez, Jesús
90	Predicting amyloid positivity and tau burden in dementia using a combination of different biomarkers	Huang \| Lin \| Huang \| Huang \| Wu \| Chang \| Hsiao	Huang, Shao-Yi
91	Evaluation of [³H]SynVesT - 1 binding in post-mortem brain tissue from control and Alzheimer’s Disease as a biomarker of synaptic loss	Kulagowska \| Lemoine \| King \| Gladstein \| Bevis \| Bonsall \| Finnema \| Spires-Jones \| Wells \| SV2A project team	Kulagowska, Laura
92	Exploring the predictive power of graph-theoretic metrics for tau pathology in cognitively unimpaired older adults	Johns \| Vin \| Abuwarda \| Fredericks	Johns, Emily
93	Tracking biomarkers accuracy for predicting progression to mild cognitive impairment	Gallego-Rudolf \| Wiesman \| Baillet \| Villeneuve	Gallego-Rudolf, Jonathan
94	Tau burden across Braak stages is associated with regionally specific amyloid accumulation: insights from the BIOCARD cohort	Rani \| Alm \| Callow \| Pettigrew \| Soldan \| Miller \| Albert \| Bakker	Rani, Nisha
95	Relationship between neuroinflammatory ER176-PET and functional connectivity in Progressive Apraxia of Speech	Singh-Reilly \| Sintini \| Satoh \| Duffy \| Utianski \| Clark \| Stephens \| Lowe \| Josephs \| Whitwell	Singh-Reilly, Neha
96	Sex moderates the association between regional tau and longitudinal cognitive decline in A4 and LEARN studies	Li \| Klinger \| Seto \| Birkenbihl \| Farrell \| Thibault \| Rissman \| Properzi \| Schultz \| Townsend \| Yang \| Johnson \| Reman \| Langford \| Donohue \| Sperling \| Buckley \| Coughlan	Li, Annie
97	Evaluation of the Uni-tau and CenTauR frameworks in new datasets for tau PET harmonization in Alzheimer’s disease	Lutz \| Olafson \| Tonietto \| Klein \| Pascoal \| Negrini \| Povala \| Leuzy \| Raket \| Doren \| Sanabria Bohorquez \| Teng	Lutz, Olivia
98	Hemispheric lateralization of tau-related network dysfunction and its association with neuropsychiatric symptoms in preclinical Alzheimer’s disease	Moret \| Vin \| Fredericks	Moret, Sophia
99	Characterization and correction of extracerebral [18F]MK-6240 tau PET off-target signal in Alzheimer's disease	Olafson \| Tonietto \| Doren \| Sanabria Bohórquez	Olafson, Emily
100	Investigation of optimal intensity threshold for tau-PET overlap index	Lim \| Lee \| Min \| Moloney \| Mester \| Ghatamaneni \| Senjem \| Nguyen \| Graff-Radford \| Schwarz \| Gunter \| Kantarci \| Boeve \| Vemuri \| Jones \| Jack \| Petersen \| Murray \| Lowe	Lim, Seokbeen
101	DeepSUVR: Towards redefining the Centiloid masks using a data-driven approach	Bourgeat \| Fripp \| Lebrat \| Gillman \| Cox \| Goyal \| Tosun-Turgut \| LaMontagne \| Benzinger \| Weiner \| Morris \| Villemagne \| Masters \| Rowe \| Dore	Bourgeat, Pierrick
102	Mechanical stress of the entorhinal cortex: A potential driver of tau pathology?	Zhang \| Crary \| Provenzano	Provenzano, Frank
103	Amyloid-Tau to neurodegeneration mismatch from inter-modality image translation using deep learning	Lyu \| Yushkevich \| Dong \| Khandelwal \| Brown \| Duong \| Li \| Xie \| Wisse \| Das \| Wolk	Lyu, Xueying
104	Tau PET subgroups differ in network patterns of functional connectivity and amyloid PET	Millar \| Doering \| Adeyemo \| McKay \| Metcalf \| Roman \| Canfield \| Jindal \| Flores \| Strain \| Wisch \| Hassenstab \| Schindler \| Morris \| Gordon \| Ances \| Benzinger	Millar, Peter
105	Cortical freewater increases with tau tangle aggregation	Hall \| Aumont \| Rahmouni \| Therriault \| Hosseini \| Trudel \| Fernandez-Arias \| Macedo \| Servaes \| Bezgin \| Wang \| Zheng \| Stevenson \| Sanjeewa \| Benedet \| Triana-Baltzer \| Kolb \| Ashton \| Zetterberg \| Blennow \| Pascoal \| Klostranec \| Rosa-Neto	Hall, Brandon
106	Distinct spatiotemporal patterns of vascular disease in Alzheimer’s disease subtypes	Ottoy \| Yin \| Kang \| Gibson \| Clappison \| Yang \| Carver \| Rahmouni \| Stevenson \| Servaes \| Therriault \| Pascoal \| Soucy \| Gauthier \| Black \| Rosa-Neto \| Goubran	Ottoy, Julie
107	Annual percent change of microglia density in relation to tau accumulation in older adults	Houlihan \| Johnson \| Smith \| Guzman \| Okafor \| Heuer \| Sanchez \| Talmasov \| Chikwem \| Dass \| Noble \| Kreisl \| Small \| Lao	Houlihan, Hannah
108	Physical frailty as a risk factor for increased tau accumulation and cognitive decline in cognitively unimpaired older adults	Palmgren \| Matos \| Kirn \| Robinson \| Pintucci \| Properzi \| Schultz \| Amariglio \| Rentz \| Johnson \| Sperling \| Chhatwal \| Yau	Palmgren, Kailee
109	Assessing neuroinflammation in Alzheimer's disease: A TSPO-PET study using ER176 and its correlation with amyloid and tau pathology	Kandimalla \| Jacobson \| Lim \| Lee \| Min \| Botha \| Graff-Radford \| Jones \| Vemuri \| Kantarci \| Knopmam \| Jack \| Petersen \| Lowe	Jacobson, David
110	Two distinct sources of 18F-MK-6240 off-target signal identified by individualized head modeling and PET kinetics	Chen \| Fu \| Puonti \| Thibault \| Johnson \| Price	Chen, Charles
112	TSPO PET mediates tau-associated neurodegeneration in limbic and temporal regions across clinical variants of Alzheimer’s disease	Lao \| Johnson \| Smith \| Guzman \| Houlihan \| Okafor \| Heuer \| Sanchez \| Talmasov \| Chikwem \| Dass \| Noble \| Kreisl \| Small	Lao, Patrick
114	Tracking plasma biomarker abnormalities with amyloid time accumulation	Bluma \| Chiotis \| Bucci \| Savitcheva \| Matton \| Kivipelto \| Jeromin \| De Santis \| Di Molfetta \| Ashton \| Blennow \| Zetterberg \| Nordberg	Bluma, Marina
115	Advancing antibody-based pretargeted PET imaging of protein aggregates in the brain	Gustavsson \| Honer \| Hvass \| Shalgunov \| Clausen \| Stotz \| Wünsche \| Lopes van den Broek \| Knudsen \| Aldana \| Niewoehner \| Gobbi \| Kustermann \| Battisti \| Kjær \| Herth	Honer, Michael
116	Longitudinal change in mnemonic discrimination and influence of Aβ burden	Kraft \| Nair \| Gonen \| Skotnicki \| Rodrigue \| Kennedy	Kraft, Jessica

POSTER SESSIONS: 3A - Friday, January 17, 10:45 - 11:40 am; 3B - Friday, January 17, 2:55 - 3:50 pm

Board #	Title	Authors	Presenter
117	Concordance between visual and quantitative amyloid PET and CSF biomarkers in the ADNI-DOD cohort	Vrillon \| Blazhenets \| Lagarde \| Chiotis \| Abu Raya \| Soleimani-Meigooni \| Rabinovici \| Weiner \| Silbert \| Hantke \| Schwartz \| Livny Ezer \| Lesman Segev \| Yaffe \| Shaw \| Landau \| La Joie \| Gardner	Vrillon, Agathe
118	Calibration of multi-site raters for prospective visual read of amyloid PET scans acquired across the ADRC Consortium for Clarity in ADRD Research Through Imaging (CLARiTI)	Soleimani-Meigooni \| Blazhenets \| La Joie \| Lin \| Soppe \| Johnson \| Koran \| McConathy \| Nasrallah \| Tanner \| Villemagne \| Windon \| Zeineh \| Mormino \| Johnson \| Rabinovici	Soleimani-Meigooni, David
119	Evaluating the effect of APOE genotype in real-world clinical settings: results from the IDEAS-ANGI study	Pezzoli \| Jonson \| Blazhenets \| Schonhaut \| Perez \| Oddi \| Castruita \| Casaletto \| Hanna \| March \| Gatsonis \| Carrillo \| Foroud \| La Joie \| Yokoyama \| Rabinovici	Pezzoli, Stefania
120	Brain connectivity drives tau distribution while regional vulnerability drives tau load in Alzheimer’s disease	Xiao \| Bazinet \| Strandberg \| Hansen \| Shafiei \| Spotorno \| Behjat \| Stomrud \| Smith \| Palmqvist \| Mattsson-Carlgren \| Dagher \| Misic \| Hansson \| Vogel	Xiao, Yu
121	Synergistic effects of peripheral inflammation and neuroinflammation on amyloid, vascular, and neurodegeneration markers across the Alzheimer’s disease spectrum	Ramirez Tirado \| Cohen \| Shaaban \| Matan \| Lopresti \| Ikonomovic \| Karikari \| Villemagne \| Lopez	Ramirez Tirado, Laura
122	Impact of amyloid removal on cerebral volume changes with Gantenerumab	Tonietto \| Silvestri \| Belder \| Barkhof \| Fox \| Smith \| Klein	Tonietto, Matteo
123	Astrocyte reactivity explains tau-related effects on hippocampal dysfunction and longitudinal atrophy in preclinical Alzheimer’s disease	Schweitzer \| Iordanova \| Chen \| Jin \| Thurston \| Lopresti \| Snitz \| Tudorascu \| Cohen \| Kamboh \| Halligan-Eddy \| Karikari \| Villemagne \| Aizenstein \| Wu	Schweitzer, Noah
124	Plasma phosphorylated tau 217 and longitudinal trajectories of Aβ, tau, and cognition in cognitively unimpaired older adults	Yang \| Anzai \| Yau \| Román Viera \| Maa \| Kirn \| Properzi \| Schultz \| Farrell \| Jacobs \| Buckley \| Papp \| Marshall \| Amariglio \| Rentz \| Braunstein \| Johnson \| Sperling \| Chhatwal	Yang, Hyun-Sik
125	Detection of TDP-43 from plasma-derived astrocyte extracellular vesicles for identification of LATE	Rissman	Rissman, Robert
126	Short sleep duration is associated with higher subsequent plasma p-tau217 in aging	Winer \| Cody \| Young \| Mormino	Winer, Joseph
127	Impacts of testing language and rates of amyloid positivity among underrepresented groups in the A4 Study	Sai \| D. Grill \| C. Mormino \| B Young	Sai, Isha
128	Lower locus coeruleus metabolism is associated with greater year-to-year intraindividual cognitive variability in older individuals with elevated levels of Alzheimer’s disease pathology	Wiklund \| Van Egroo \| Koops \| Hanseeuw \| Papp \| Rentz \| Sperling \| Johnson \| Jacobs	Wiklund, Emma
129	Long-term cognitive and biomarker trajectories of cognitively unimpaired individuals with elevated plasma ptau-217	Silva-Rodríguez \| Zhang \| Valeriano-Lorenzo \| López-González \| Wagner-Reguero \| del Ser \| Grothe \| Sánchez-Juan	Silva-Rodríguez, Jesús
130	A large public release of PIB PET and MRI from the Mayo Clinic Study of Aging	Schwarz \| Kremers \| Prakaashana \| Przybelski \| Christenson \| Williams \| Gunter \| Senjem \| Arani \| Reid \| Machulda \| Fields \| Lowe \| Kantarci \| Graff-Radford \| Vemuri \| Petersen \| Knopman \| Jack	Schwarz, Christopher
131	Harmonizing visual readings of Flortaucipir and MK-6240 using head-to-head data	Ruppert \| Medeiros \| Rocha \| Soares \| Amaral \| Povala \| Bauer-Negrini \| L. Ferreira \| Lussier \| Oliveira Jr. \| Scarpatto Rodrigues \| Mroue \| Zalzale \| Leffa \| Saha \| Bellaver \| L. Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| A. Gordon \| Rosa-Neto \| Baker \| A. Pascoal	Ruppert, Emma
132	Twin-mapping techniques in clinical trials: a proof-of-concept application to the Internet-Based Conversational Engagement Clinical Trial (I-CONECT)	Wu \| Chen \| Arnold \| Dodge	Wu, Chao-Yi
133	Effects of amyloid and tau status on multiplex plasma CNS and inflammatory proteins in a normal aging cohort	Trelle \| Cody \| Nguyen \| Winer \| Weiss \| Romero \| Sai \| Wilson \| Wagner \| Maecker \| Mormino	Cody, Karly
134	Tau imaging thresholds within NIA-AA multilevel tau staging as predictors of tau accumulation and cognitive decline in non-demented individuals	Gogola \| Cohen \| Snitz \| Minhas \| Tudorascu \| Ikonomovic \| Shaaban \| Dore \| Matan \| DelBene \| Bourgeat \| Leuzy \| Aizenstein \| Lopez \| Lopresti \| Villemagne	Gogola, Alexandra
135	Multi-morbidity and Alzheimer’s disease pathology across the lifespan in adults with Down syndrome	Smith \| Edwards \| Flores Aguilar \| Alshikho \| Tudorascu \| Rosas \| Yassa \| Hartley \| Handen \| Christian \| Gutierrez \| Wilcock \| Head \| Brickman \| Lao	Smith, Anna
136	Cortical atrophy is correlated with the discrepancy between neuroradiological assessment and binary quantitation of florbetapir PET in nondemented older adults	Schwartz \| Villamizar Alvarado \| Szidonya \| Choudhary \| Marcoe \| Mar \| Gillan \| Hendricks \| Kaye \| Silbert	Schwartz, Daniel
137	Vascular pathology influences the association of tau-PET with neurodegeneration and cognition in Aβ-negative individuals	Silva Oliveira Junior \| Bellaver \| C.L. Ferreira \| Povala \| Bauer-Negrini \| Lussier \| do Amaral \| Rodrigues \| da Rocha \| Saha \| Ruppert \| Soares \| Leffa \| Felix \| Mroue \| Tudorascu \| Zalzale \| Pascual \| Gordon \| Lowe \| Oh \| Soleimani-Meigooni \| Fortea \| Rosa-Neto \| Baker \| Pascoal	Silva Oliveira Junior, Markley
138	Concomitant neurodegeneration of the lateral hypothalamus and locus coeruleus is associated with early Alzheimer’s disease-related pathophysiological and cognitive processes	Van Egroo \| Baillet \| Becker \| Price \| Properzi \| Papp \| Rentz \| Sperling \| Johnson \| Jacobs	Van Egroo, Maxime
139	Amyloid-associated hyperconnectivity drives tau spreading across connected brain regions in Alzheimer’s disease	Roemer-Cassiano \| Wagner \| Evangelista \| Dehsarvi \| Steward \| Dewenter \| Biel \| Zhu \| Malpetti \| Höglinger \| Brendel \| Jäkel \| Scholl \| Franzmeier	Roemer-Cassiano, Sebastian Niclas
140	Association of plasma GFAP with tau PET in cognitively unimpaired Aβ-negative subjects	Saha \| Bellaver \| Povala \| Ferreira \| Bauer-Negrini \| Silva \| Lussier \| Rodrigues \| Oliveira \| Rocha \| Felix \| Ruppert \| Medeiros \| Katz \| Masdeu \| Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Saha, Pampa
141	The striatum is an early, accurate indicator of [C-11]PiB amyloid burden for the Down syndrome population	McLachlan \| Price \| Tudorascu \| Laymon \| Lao \| Handen \| Fryer \| Ances \| Johnson \| Betthauser \| Zaman \| Head \| Mapstone \| Bettcher \| LeMerise \| McVea \| DiFillipo \| Zammit \| Hartley \| Christian	McLachlan, Max
142	Best practices for tau-PET tracer harmonization in Alzheimer's research	Tissot \| Tsai \| Giorgio \| Blazhenets \| Harrison \| Olafson \| Sanabria \| Leuzy \| Doré \| Jagust \| Rosa-Neto \| Pascoal \| Baker	Tissot, Cécile
143	Relationship between metabolic syndrome biomarkers and regional tau accumulation in cognitively unimpaired older adults	Tennant \| Luu \| Hand \| Lee \| Toga \| O'Bryant \| Yaffe \| Braskie	Tennant, Victoria
144	Association of a unique pattern of white matter T2 FLAIR hyperintensities with plasma and tau PET biomarkers in former American football players	Groh \| Farris \| Brickman \| Alshikho \| Miner \| Tripodis \| Cui \| Adler \| Balcer \| Bernick \| Cantu \| Coleman \| Dodick \| Ashton \| Zetterberg \| Blennow \| Peskind \| McKee \| Mez \| Bouix \| Cummings \| Reiman \| Stern \| Shenton \| Alosco	Groh, Jenna
145	Relationship between flortaucipir-PET and quantitative susceptibility mapping in atypical Alzheimer’s disease	Singh-Reilly \| Satoh \| Graff-Radford \| Machulda \| Lowe \| Josephs \| Whitwell	Singh-Reilly, Neha
146	Neuropathological evaluation of the off-target binding of flortaucipir in FTLD subcortical regions: interconnecting tau aggregates with iron deposition and neuroinflammation	Gatto \| Youssef \| Uruk \| Fu \| Reichard \| Lowe \| Whitwell \| Josephs	Gatto, Rodolfo
147	Patterns of cognitive decline in individuals with elevated p-tau217 and low levels (<20 Centiloids) of neocortical Aβ-PET signal	Townsend \| Properzi \| Klinger \| Schultz \| Coughlan \| Yau \| Birkenbihl \| Seto \| Hanseeuw \| Jacobs \| Farrell \| Yang \| Papp \| Rentz \| Johnson \| Sperling \| Chhatwal \| Amariglio \| Buckley	Townsend, Diana
148	Anatomic specificity of inflammation TSPO PET biomarkers in dementia	Finn \| Faridar \| Toledo \| Nakawah \| Roman \| Masdeu \| Pascual	Pascual, Belen
149	Head-to-head comparison of longitudinal plasma assays in relation to longitudinal amyloid pathology in Alzheimer’s disease	Yakoub \| Qiu \| Villeneuve \| Pichet Binette \| ADNI Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium	Yakoub, Yara
150	Characterization of PART using MK-6240, Flortaucipir, and plasma p-tau217	Soares \| L. Ferreira \| Ruppert \| S. Medeiros \| Rocha \| Bellaver \| Povala \| Bauer-Negrini \| Amaral \| Bloomquist \| Lussier \| Masdeu \| L. Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| A. Gordon \| Rosa-Neto \| Baker \| A. Pascoal	Soares, Carolina
151	Longitudinal rate of change in CSF biomarkers is associated with subsequent Tau PET burden in Braak stages I and II: Findings from the BIOCARD study	Rani \| Moghekar \| Callow \| Alm \| Pettigrew \| Soldan \| Miller \| Wang \| Albert \| Bakker	Rani, Nisha
152	Head-to-head comparison of four tau-PET tracers for in vivo Braak staging: the HEAD Study	Cassa Macedo \| Rahmouni \| Tissot \| Therriault \| Servaes \| Wang \| Trudel \| Aumont \| Hall \| Chan \| Zheng \| Lussier \| Ferreira \| Bellaver \| Povala \| Pascual \| Gordon \| Lowe \| Oh \| Soleimani-Meigooni \| Baker \| Pascoal \| Rosa-Neto	Cassa Macedo, Arthur
153	Astrogliosis in the early-stages of Alzheimer's disease	Dore \| Bourgeat \| Harada \| Furumoto \| Mulligan \| Xia \| Paranawithana \| Laws \| Feizpour \| Bozinovski \| Huang \| Lopresti \| Ikonomovic \| Fripp \| Okamura \| Rowe \| Villemagne	Villemagne, Victor
154	Identifying an optimal aβ cutoff point for progression from mild cognitive impairment to Alzheimer’s disease: comparing cognitive performance and aβ pet insights	Shishegar \| Bourgeat \| Dore \| Laws \| Porter \| Weiner \| Masters \| Maruff \| Sohrabi \| Fripp \| Villemagne \| Rowe	Bourgeat, Pierrick
155	Amyloid modifies the association between late-life BMI and longitudinal cognition in cognitively unimpaired individuals	Yau \| Raman \| Wang \| Aggarwal \| Brickman \| Chhatwal \| Cogswell \| Graff-Radford \| Pillai \| Rafii \| Aisen \| Sperling \| A4 and Learn Study Teams	Yau, Wai-Ying Wendy
156	Amyloid spatial extent captures early tau burden and cognitive deficits, measured by PACC and digital clock drawing test, in preclinical Alzheimer’s disease	Thompson \| Fu \| Farrell \| Thibault \| Slade \| Del Carmen Montenegro \| Robinson \| Jutten \| Davis \| Penney \| Rodriguez Alonso \| Sperling \| Rentz \| Price \| Johnson	Thompson, Jackson
157	Findings from dynamic [18F]-MK6240 PET imaging after motion and partial volume corrections	Tiss \| Gong \| Lois \| Dhaynaut \| Guehl \| El Fakhri \| Johnson \| Ouyang	Tiss, Amal
158	Harmonization of MK6240 and Flortaucipir Braak Staging	Rocha \| Bellaver \| Ruppert \| L. Ferreira \| Soares \| Medeiros \| Povala \| Amaral \| Bauer-Negrini \| Lussier \| Scarpatto Rodrigues \| Oliveira Jr. \| Saha \| Bloomquist \| Masdeu \| L. Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| A. Gordon \| Rosa-Neto \| Baker \| A. Pascoal	Rocha, Andreia
159	Comparison of MK-6240 PET and Flortaucipir tau PET imaging for the biological staging of Alzheimer’s disease	Scop Medeiros \| L. Ferreira \| Bellaver \| Ruppert \| Zalzale \| Soares \| Povala \| Bauer-Negrini \| Rocha \| S. Rodrigues \| Oliveira \| Mroue \| Saha \| Amaral \| Lussier \| Bloomquist \| L. Tudorascu \| Masdeu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| A. Gordon \| Rosa-Neto \| P. Schilling \| Baker \| A. Pascoal	Scop Medeiros, Marina
160	Impact of early-stage amyloidosis on tau accumulation throughout the medial temporal lobe and neocortex	Slade \| Thibault \| Thompson \| Fu \| Becker \| Price \| Tiss \| Gong \| Sperling \| Johnson \| Farrell	Slade, Elliott
161	Associations between age-related tau deposition and neural selectivity in cognitively unimpaired older adults	Sheng \| Trelle \| Young \| Romero \| Park \| Sai \| Vossler \| Wagner \| Mormino	Sheng, Jintao
162	Posterior white matter hyperintensity is related to the emergence of lobar cerebral microbleeds in ADNI	Saukkonen \| Yang \| Loghmani \| Schultz \| Greenberg \| Sperling \| Chhatwal \| Shirzadi	Saukkonen, Daniel
163	Defining the grey zone thresholds for tau PET positivity using the Uni𝜏 scale	Povala \| Bellaver \| Bauer-Negrini \| Ruppert \| Medeiros \| Amaral \| Lussier \| Lukasewicz \| Soares \| Tudorascu \| Masdeu \| Pascual \| Gordon \| Lowe \| Oh \| Soleimani-Meigooni \| Rosa-Neto \| Baker \| A. Pascoal	Povala, Guilherme
164	Neocortical amyloid spatial extent predicts cognitive decline over time in memory and executive function domains	Thibault \| Fu \| Thompson \| Slade \| Jacobs \| Price \| Rentz \| Sperling \| Johnson \| Farrell	Thibault, Emma
165	Patterns of tau-PET accumulation and clinical progression according to biological AD stages	Trudel \| Therriault \| Rahmouni \| Cassa Macedo \| Servaes \| Aumont \| Hosseini \| Fernandez-Arias \| Zheng \| Wang \| Chan \| Hall \| Stevenson \| Hopewell \| Hung-Hsin Hsiao \| Gauthier \| Vitali \| Pascoal \| Rosa-Neto	Trudel, Lydia
166	The Tau Progression Index (TPI): an individualized, clinically applicable, multimodally-derived score to predict AD progression	Chiang \| Butler \| Ghaderi Yazdi \| Ozoria \| Chernek \| Calimag \| Blum \| Pahlajani \| Foldi \| Khalafi \| Devanand \| He \| Hojjati \| Gholipour Picha \| Habeck \| Stern \| Razlighi	Razlighi, Qolamreza
167	Dried plasma spot optimization for the NULISAseq CNS panel	Wilson \| Rea Reyes \| Fredricks \| team \| Rusch \| VandenLangenberg \| Jensen \| Marshall \| Keske \| Weninger \| Jeffers \| Huber \| Johnson \| Zetterberg	Wilson, Rachael
168	Clinical validation of the Lumipulse G1200 automated immunoassay for the measurement of Alzheimer’s disease plasma biomarkers	Chan \| Rahmouni \| Zheng \| Congalves \| Macedo \| Aumont \| Therriault \| Hall \| Wang \| Trudel \| Servaes \| Fernandez-Arias \| Hopewell \| Zetterberg \| Pascoal \| Benedet \| Rosa-Neto	Chan, Tevy
169	Sex differences in synaptic loss in early Alzheimer’s disease	Galbraith \| Abuwarda \| O'Dell \| Mecca \| van Dyck \| Fredericks	Galbraith, Jordan
170	Assessing the generalizability of AD subtypes across diverse cohorts: HABS-HD and ADNI	An \| Gordon \| Sotiras \| Millar \| O'Bryant \| Ances \| Meeker	An, Gordon Zhaoqi
171	Locus coeruleus - medial temporal lobe functional connectivity confers protection against amyloid-related cognitive decline in the context of high cognitive reserve	Heinrich \| Prokopiou \| Wiklund \| Papp \| Rentz \| Sperling \| Johnson \| Jacobs	Heinrich, Lukas
172	Effect of AD risk factors on tau-PET tracer uptake and its association with amyloid-β pathology	Rodrigues \| Bellaver \| Povala \| Bauer-Negrini \| Lussier \| Lulasewicz Ferreira \| Silva Oliveira Junior \| Rocha \| Saha \| Rupert \| Scop Medeiros \| Masdeu \| Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Rodrigues, Matheus
173	PI-2620 uptake in the medial temporal lobes discriminates Alzheimer’s disease from normal cognition and non-Alzheimer’s dementias	Phillips \| Temirova \| Kamel \| Hareras \| Ibe \| Hlava \| Xie \| Cousins \| Shaw \| Das \| Maneval \| Manning \| Brown \| Lopez \| Keegan \| Stephens \| McMillan \| Irwin \| Li \| Nasrallah \| Wolk	Phillips, Jeffrey
174	Characterizing associations with Aβ burden in non-Hispanic Black participants across US POINTER and A4/LEARN cohorts	Robinson \| Papp \| Harrison \| Baker \| Snyder \| Sperling \| Amariglio \| Landau \| STUDYTEAM \| Study Group	Robinson, Talia

HUMAN AMYLOID IMAGING CONFERENCE

HAI 2025 POSTER SESSIONS

POSTER SESSIONS: 1A - Wednesday, January 15 - 10:40 am - 12:35 pm; 1B - Wednesday, January 15, 4:30 - 5:25 pm

POSTER SESSIONS: 2A - Thursday, January 16 - 10:05 - 11:00 am; 2B - Thursday, January 16, 3:55 - 4:50 pm

POSTER SESSIONS: 3A - Friday, January 17, 10:45 - 11:40 am; 3B - Friday, January 17, 2:55 - 3:50 pm

HAI Past Poster Sessions